RE-BVS – Piemonte Repository

Sfoglia per AUTORE
CUCCI A
Collezione AOU San Luigi di Orbassano

Items : 6

Patient-Specific iPSC-Derived Endothelial Cells Provide Long-Term Phenotypic Correction of Hemophilia A. in Stem cell reports / Stem Cell Reports. 2018 Dec 11;11(6):1391-1406. doi: 10.1016/j.stemcr.2018.10.012. Epub 2018 Nov 8.

2018
ASL Torino 5
AOU San Luigi di Orbassano
AOU Città della Salute di Torino

Schinco P; Lombardo A; Raya A; Messina M; Faraldi F; Prat M; Valeri F; Borsotti C; Berta GN; Di Scipio F; Colangelo D; Ranaldo G; Merlin S; Cucci A; Richaud-Patin Y; Follenzi A; Olgasi C; Talmon M; Olgasi C; Talmon M; Merlin S; Cucci A; Richaud-Patin Y; Ranaldo G; Colangelo D; Di Scipio F; Berta GN; Borsotti C; Valeri F; et alii...

Alemtuzumab long-term immunologic effect: Treg suppressor function increases up to 24 months. in Neurology(R) neuroimmunology & neuroinflammation / Neurol Neuroimmunol Neuroinflamm. 2016 Jan 21;3(1):e194. doi: 10.1212/NXI.0000000000000194. eCollect

2016
AOU San Luigi di Orbassano
AOU Città della Salute di Torino

Clerico M; Durelli L; Novelli F; Annovazzi P; Horakova D; Adamec I; Habek M; Soldo-Butkovic S; Vladic A; Cocco E; Bardina V; Cucci A; Rolla S; De Mercanti S;

Long-term follow-up of ultrasound-guided botulinum toxin-A injections for sialorrhea in neurological dysphagia. in Journal of neurology / J Neurol. 2015 Dec;262(12):2662-7. doi: 10.1007/s00415-015-7894-1. Epub 2015 Sep 26.

2015
AOU San Luigi di Orbassano
AOU Città della Salute di Torino

Durelli L; Chio' A; Calvo A; Avagnina P; Veltri A; Cucci A; De Mercanti S; Artusi CA; Tinivella M; Busso M; Barbero P; Clerico M;

Pro-inflammatory cytokine and chemokine mRNA blood level in multiple sclerosis is related to treatment response and interferon-beta dose. in Journal of neuroimmunology / J Neuroimmunol. 2010 Sep 14;226(1-2):150-7. doi: 10.1016/j.jneuroim.2010.05.038. Epub 2010 Jun 23.

2010
AOU San Luigi di Orbassano

Cucci A; Barbero P; Clerico M; Ferrero B; Versino E; Contessa G; Demercanti S; Viglietta E; Di Liberto A; Vai AG; Durelli L;

Neutralizing antibodies in multiple sclerosis patients treated with 375 micrograms interferon-beta-1b. in Expert opinion on biological therapy / Expert Opin Biol Ther. 2009 Apr;9(4):387-97. doi: 10.1517/14712590902762781.

2009
AOU San Luigi di Orbassano

Durelli L; Barbero P; Cucci A; Ferrero B; Ricci A; Contessa G; De Mercanti S; Ripellino P; Lapuma D; Viglietta E; Bergui M; Versino E; Clerico M;

High-dose, frequently administered interferon beta therapy for relapsing-remitting multiple sclerosis must be maintained over the long term: the interferon beta dose-reduction study. in Journal of the neurological sciences / J Neurol Sci. 2004 Jul 15;222(1-2):13-9. doi: 10.1016/j.jns.2004.03.023.

2004
AOU San Luigi di Orbassano

Barbero P; Verdun E; Bergui M; Pipieri A; Clerico M; Cucci A; Ricci A; Bergamasco B; Durelli L;